GLOBAL MEDICAL REIT INC (GMRE) Stock Analyst Earnings Estimates
NYSE:GMRE - New York Stock Exchange, Inc. - US37954A2042 - REIT - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 137.3M 18.46% | 141.049M 2.73% | 138.78M -1.61% | 144.96M 4.45% | 150.18M 3.60% | 152.8M 1.74% | 153.88M 0.71% | |
| EBITDA YoY % growth | 95.44M 13.63% | 95.936M 0.52% | 87.96M -8.31% | 101.52M 15.42% | 109.7M 8.06% | 106.9M -2.55% | 118.32M 10.68% | |
| EBIT YoY % growth | 38.8M 4.30% | 37.979M -2.12% | 33.047M -12.99% | 38.621M 16.87% | 40.787M 5.61% | 44.982M 10.29% | 51.306M 14.06% | |
| Operating Margin | 28.26% | 26.93% | 23.81% | 26.64% | 27.16% | 29.44% | 33.34% | |
| EPS YoY % growth | 0.20 5.26% | 0.23 15.00% | 0.04 -82.61% | 0.12 195.80% | 0.15 25.00% | 0.09 -37.93% | 0.09 |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.03 161.20% | 0.03 10.50% | 0.03 -33.70% | 0.03 -9.32% | 0.02 -33.33% | 0.02 -28.22% | 0.02 -28.22% |
| Revenue Q2Q % growth | 36.08M 5.37% | 36.409M 6.26% | 37.177M 5.75% | 36.976M 6.81% | 38.4M 6.43% | 38.854M 6.72% | 39.309M 5.73% |
| EBITDA Q2Q % growth | 24.654M -32.07% | 25.263M -49.69% | 25.685M -58.25% | 25.935M 11.89% | 28.503M 15.61% | 29.292M 15.95% | 30.083M 17.12% |
| EBIT Q2Q % growth | 8.613M 2.26% | 9.297M 5.60% | 10.354M 56.52% | 9.41M -1.84% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.03 200.00% | 0.01 | 0.02 | 135.29% |
| Q4 2024 Q2Q % growth | 0.05 600.00% | 0.00 | 0.05 | % |
| Q3 2024 Q2Q % growth | 0.03 -40.00% | 0.02 | 0.01 | 26.07% |
| Q2 2024 Q2Q % growth | -0.05 -127.78% | 0.00 | -0.05 | % |
| Q1 2024 Q2Q % growth | 0.01 | 0.00 | 0.01 | 194.41% |
| Q4 2023 Q2Q % growth | -0.01 -200.00% | 0.02 | -0.03 | -165.36% |
| Q3 2023 Q2Q % growth | 0.05 -58.33% | 0.01 | 0.04 | 250.14% |
| Q2 2023 Q2Q % growth | 0.18 500.00% | 0.02 | 0.16 | 1,076.47% |
| Q1 2023 Q2Q % growth | 0.01 -75.00% | 0.02 | -0.01 | -34.64% |
| Q4 2022 Q2Q % growth | 0.01 -83.33% | 0.03 | -0.02 | -64.35% |
| Q3 2022 Q2Q % growth | 0.12 100.00% | 0.04 | 0.08 | 226.80% |
| Q2 2022 Q2Q % growth | 0.03 -25.00% | 0.05 | -0.02 | -38.08% |
| Q1 2022 Q2Q % growth | 0.04 33.33% | 0.05 | -0.01 | -26.47% |
| Q4 2021 Q2Q % growth | 0.06 200.00% | 0.07 | -0.01 | -13.49% |
| Q3 2021 Q2Q % growth | 0.06 50.00% | 0.06 | 0.00 | 6.95% |
| Q2 2021 Q2Q % growth | 0.04 | 0.05 | -0.01 | -18.30% |
| Q1 2021 Q2Q % growth | 0.03 | 0.04 | -0.01 | -15.97% |
| Q4 2020 Q2Q % growth | 0.02 -33.33% | 0.04 | -0.02 | -50.98% |
| Q3 2020 Q2Q % growth | 0.04 100.00% | -0.12 | 0.16 | 132.14% |
| Q2 2020 Q2Q % growth | 0.00 -100.00% | 0.03 | -0.03 | -100.00% |
| Q1 2020 Q2Q % growth | 0.03 50.00% | 0.04 | -0.01 | -19.79% |
| Q4 2019 Q2Q % growth | 0.03 | 0.05 | -0.02 | -36.06% |
| Q3 2019 Q2Q % growth | 0.02 | 0.03 | -0.01 | -38.73% |
| Q2 2019 Q2Q % growth | 0.03 | 0.06 | -0.03 | -48.10% |
| Q1 2019 Q2Q % growth | 0.02 | 0.02 | 0.00 | -12.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 34.618M -1.42% | 36.089M | -1.471M | -4.08% |
| Q4 2024 Q2Q % growth | 35.157M 6.66% | 35.32M | -163K | -0.46% |
| Q3 2024 Q2Q % growth | 34.264M -3.50% | 35.338M | -1.074M | -3.04% |
| Q2 2024 Q2Q % growth | 34.241M -5.80% | 35.125M | -884K | -2.52% |
| Q1 2024 Q2Q % growth | 35.118M -3.07% | 34.617M | 501K | 1.45% |
| Q4 2023 Q2Q % growth | 32.962M -9.22% | 36.353M | -3.391M | -9.33% |
| Q3 2023 Q2Q % growth | 35.507M 0.27% | 36.72M | -1.213M | -3.30% |
| Q2 2023 Q2Q % growth | 36.351M 7.87% | 37.021M | -670K | -1.81% |
| Q1 2023 Q2Q % growth | 36.23M 13.64% | 37.347M | -1.117M | -2.99% |
| Q4 2022 Q2Q % growth | 36.31M 19.68% | 36.669M | -359K | -0.98% |
| Q3 2022 Q2Q % growth | 35.41M 18.11% | 35.424M | -14K | -0.04% |
| Q2 2022 Q2Q % growth | 33.7M 19.25% | 33.457M | 243K | 0.73% |
| Q1 2022 Q2Q % growth | 31.88M 16.56% | 32.058M | -178K | -0.56% |
| Q4 2021 Q2Q % growth | 30.34M 21.70% | 31.235M | -895K | -2.87% |
| Q3 2021 Q2Q % growth | 29.98M 19.44% | 29.875M | 105K | 0.35% |
| Q2 2021 Q2Q % growth | 28.26M 28.11% | 29.204M | -944K | -3.23% |
| Q1 2021 Q2Q % growth | 27.35M 26.33% | 26.277M | 1.073M | 4.08% |
| Q4 2020 Q2Q % growth | 24.93M 21.91% | 26.12M | -1.19M | -4.56% |
| Q3 2020 Q2Q % growth | 25.1M 37.91% | 23.137M | 1.963M | 8.48% |
| Q2 2020 Q2Q % growth | 22.06M 30.69% | 22.344M | -284K | -1.27% |
| Q1 2020 Q2Q % growth | 21.65M 42.43% | 21.68M | -30K | -0.14% |
| Q4 2019 Q2Q % growth | 20.45M | 19.87M | 580K | 2.92% |
| Q3 2019 Q2Q % growth | 18.2M | 18.1M | 100K | 0.55% |
| Q2 2019 Q2Q % growth | 16.88M | 16.93M | -50K | -0.30% |
| Q1 2019 Q2Q % growth | 15.2M | 15.321M | -121K | -0.79% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 200% | 28.59% | 60% | 28.89% |
| Revenue | -0.48% | -2.84% | -0.17% | -2.63% |